Qube Research & Technologies (QRT)
DNTH icon

Qube Research & Technologies (QRT)’s Dianthus Therapeutics DNTH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.2M Sell
160,743
-36,181
-18% -$3.76M 0.01% 1229
2026
Q2 		$19.2M Buy
196,924
+166,570
+549% +$14.5M 0.02% 934
2026
Q1 		$2.55M Buy
30,354
+20,060
+195% +$1.16M ﹤0.01% 2033
2025
Q4 		$424K Buy
+10,294
New +$399K ﹤0.01% 2849
2024
Q4 		– Sell
-7,753
Closed -$212K – 3537
2024
Q3 		$212K Sell
7,753
-3,452
-31% -$96.2K ﹤0.01% 2567
2024
Q2 		$290K Sell
11,205
-56,641
-83% -$1.36M ﹤0.01% 2318
2024
Q1 		$2.04M Buy
67,846
+67,044
+8,360% +$1.46M ﹤0.01% 1747
2023
Q4 		$8.34K Buy
802
+799
+26,633% +$8.83K ﹤0.01% 3632
2023
Q3 		$41 Buy
+3
New +$38 ﹤0.01% 3832
2022
Q4 		– Sell
-1,276
Closed -$29K – 2572
2022
Q3 		$29K Sell
1,276
-129
-9% -$3.53K ﹤0.01% 2242
2022
Q2 		$27K Buy
+1,405
New +$34.7K ﹤0.01% 2222
2021
Q3 		– Sell
-818
Closed -$128K – 2330
2021
Q2 		$128K Buy
+818
New +$150K ﹤0.01% 1896

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DNTH Position: Q3 2026 in Review

Qube Research & Technologies (QRT) reduced its Dianthus Therapeutics (DNTH) stake by 18% in Q3 2026, selling an estimated $3.76M and leaving 160,743 shares worth $14.2M. The position accounts for 0.01% of the portfolio, ranked #1229.

Qube Research & Technologies (QRT) first reported a position in DNTH in Q2 2021 and has held it in 12 quarters since. The position peaked at $19.2M in Q2 2026. 188 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Qube Research & Technologies (QRT) held 160,743 shares of Dianthus Therapeutics worth $14.2M as of Q3 2026.
  • Qube Research & Technologies (QRT) sold 36,181 Dianthus Therapeutics shares in Q3 2026, an estimated $3.76M.
  • Dianthus Therapeutics made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1229 holding.
  • Qube Research & Technologies (QRT) first reported a position in Dianthus Therapeutics in Q2 2021 and has held it in 12 quarters since.
  • Qube Research & Technologies (QRT)'s Dianthus Therapeutics position peaked at $19.2M in Q2 2026.
  • 188 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.